Unity Biotechnology, Inc.

Contributing Author

Recent Articles by Unity Biotechnology, Inc.

May-05	UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates GlobeNewswire
May-01	UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information